Transaction in Own Shares Replacement

Summary by AI ^BETAClose X

Smith & Nephew plc has amended its previous announcement regarding transactions in its own shares, confirming that between May 8 and May 14, 2026, it purchased 1,425,801 ordinary shares for $21,165,361.30 as part of its $250 million share buyback program. These purchases were executed through Merrill Lynch International on the London Stock Exchange, with an average price of 10.9495 pence per share, ranging from 10.6250p to 11.1650p. Following these transactions, the company holds 25,110,406 shares in treasury, with the total issued share capital now standing at 852,623,344 ordinary shares.

Disclaimer*

Smith & Nephew Plc

15 May 2026

The following amendment has been made to the 'Transactions in own shares' announcement released on 15 May 2026 at 11:41 AM under RNS No 5483E.

PDF link included.

All other details remain unchanged.

15 May 2026

Smith & Nephew plc
Transactions in own shares

Smith & Nephew plc (the "Company") announces that from 8 May 2026 up to and including 14 May 2026 it has purchased the following number of its own ordinary shares of US 20¢ each through Merrill Lynch International, as part of its USD $250 million share buyback programme announced on 6 May 2026 and in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 6 May 2026.

Date of purchase	Aggregate number of ordinary shares purchased	Lowest price paid per ordinary share	Highest price paid per ordinary share	Average price paid per ordinary share
8 May 2026	285,558	1,085.50p	1,116.50p	1,099.92p
11 May 2026	297,890	1,070.50p	1,098.50p	1,081.92p
12 May 2026	275,463	1,062.50p	1,104.00p	1,088.00p
13 May 2026	283,073	1,097.50p	1,112.50p	1,102.19p
14 May 2026	283,817	1,097.00p	1,108.50p	1,103.16p

The Company intends to hold these shares in Treasury and then either cancel them or retain them for the purpose of satisfying awards under the Company's employee share plans.

Since 8 May 2026, the Company has purchased 1,425,801 shares at a cost of $21,165,361.30.

Following the purchases of these shares, the Company holds 25,110,406 of its ordinary shares in treasury. The Company's issued share capital, with one voting right per share consists of 852,623,344 ordinary shares of US20¢ each (excluding treasury shares). The figure of 852,623,344 should be used by shareholders as the denominator when determining whether they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

These purchases were made by Merrill Lynch International on behalf of the Company.

This announcement is made in accordance with the requirements of UKLR 9.6.6R.

The table below contains detailed information about the purchases made as part of the buyback programme.

Schedule of Purchases

Shares purchased: 1,425,801 (ISIN: GB0009223206)

Dates of purchases: 8 May 2026 to 14 May 2026

Investment firm: Merrill Lynch International

Aggregate information:

Venue	Volume weighted average price paid per ordinary share (GBP)	Number of ordinary shares repurchased	Lowest price per ordinary share (GBP)	Highest price per ordinary share (GBP)
London Stock Exchange	10.9495	1,425,801	10.6250	11.1650
CBOE Europe BXE	-	-	-	-
CBOE Europe CXE	-	-	-	-
Turquoise	-	-	-	-
Aquis Stock Exchange	-	-	-	-

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018), a schedule of individual trades by Merrill Lynch International is available below:

Individual Transactions:

The table attached contains detailed information of the individual trades made by Merrill Lynch International, as part of the buyback programme.

Click on, or paste the following link into your web browser, to view the associated PDF document.

http://www.rns-pdf.londonstockexchange.com/rns/5671E_1-2026-5-15.pdf

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END